Pearls and myths in pleural fluid analysis
暂无分享,去创建一个
[1] R. Hehlmann,et al. Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions , 2008, Cytopathology : official journal of the British Society for Clinical Cytology.
[2] R. Davies,et al. Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose. , 2008, American journal of respiratory and critical care medicine.
[3] A. Dekker,et al. Cytology of serous effusions. An investigation into the usefulness of cell blocks versus smears. , 1978, American journal of clinical pathology.
[4] S. Bielsa,et al. Biomarkers of heart failure in pleural fluid. , 2009, Chest.
[5] J. M. Porcel,et al. Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia. , 2007, Chest.
[6] S. Sahn,et al. Thoracocentesis. Clinical value, complications, technical problems, and patient experience. , 1987, Chest.
[7] V. Villena,et al. Clinical implications of appearance of pleural fluid at thoracentesis. , 2004, Chest.
[8] Characteristics of pleural effusions associated with pulmonary embolism. , 1976, Archives of internal medicine.
[9] J. M. Porcel,et al. [Reappraisal of the standard method (Light's criteria) for identifying pleural exudates]. , 2006, Medicina clinica.
[10] J. M. Porcel,et al. The use of probrain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions resulting from heart failure , 2005, Current opinion in pulmonary medicine.
[11] J. Alegre,et al. Prospective Clinical and Microbiological Study of Pleural Effusions , 1999, European Journal of Clinical Microbiology and Infectious Diseases.
[12] R. Krenke,et al. Incidence and aetiology of eosinophilic pleural effusion , 2009, European Respiratory Journal.
[13] J. Rubins,et al. Etiology and prognostic significance of eosinophilic pleural effusions. A prospective study. , 1996, Chest.
[14] S. Martínez-Somolinos,et al. [Utility of amylase levels in malignant pleural effusions]. , 2007, Medicina clinica.
[15] J. M. Porcel,et al. Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis , 2007, Lupus.
[16] J. M. Porcel,et al. Comparing serum and pleural fluid pro‐brain natriuretic peptide (NT‐proBNP) levels with pleural‐to‐serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria , 2007, Respirology.
[17] M. Perpiñá Tordera,et al. Repeated Thoracentesis: An Important Risk Factor for Eosinophilic Pleural Effusion? , 2003, Respiration.
[18] J. M. Porcel,et al. Rentabilidad del estudio citológico del líquido pleural en el derrame maligno , 2008 .
[19] F. Vargas,et al. Influence of storage time and temperature on pleural fluid adenosine deaminase determination , 2006, Respirology.
[20] P. Kvale,et al. Volume of pleural fluid required for diagnosis of pleural malignancy. , 2002, Chest.
[21] R. Light,et al. Variations in pleural fluid WBC count and differential counts with different sample containers and different methods. , 2003, Chest.
[22] J. M. Porcel,et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. , 2004, Chest.
[23] J. M. Porcel,et al. Pleural fluid tests to identify complicated parapneumonic effusions , 2010, Current opinion in pulmonary medicine.
[24] Concepción Martín,et al. Is it meaningful to use biochemical parameters to discriminate between transudative and exudative pleural effusions? , 2002, Chest.
[25] A. Böcking,et al. Immunocytochemical identification of carcinomas of unknown primary in serous effusions , 2005, Diagnostic cytopathology.
[26] P. Kvale,et al. Prospective study to determine the volume of pleural fluid required to diagnose malignancy. , 2009, Chest.
[27] T. Yoshida. [Antinuclear antibody]. , 2020, Nihon Ishikai zasshi. Journal of the Japan Medical Association.
[28] I. Aranda,et al. Biochemical and cytologic characteristics of pleural effusions secondary to pulmonary embolism. , 2002, Chest.
[29] M. Raffeld,et al. Diagnostic effects of prolonged storage on fresh effusion samples , 2007, Diagnostic cytopathology.
[30] E. Bateman,et al. Utility of quantitative T-cell responses versus unstimulated interferon-γ for the diagnosis of pleural tuberculosis , 2009, European Respiratory Journal.
[31] J. M. Porcel,et al. Establishing a diagnosis of pleural effusion due to heart failure , 2009, Respirology.
[32] J. M. Porcel,et al. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. , 2010, European journal of internal medicine.
[33] S. Pervez,et al. Diagnostic value of clot examination for malignant cells in serous effusions , 2009, Cytopathology : official journal of the British Society for Clinical Cytology.
[34] J. M. Porcel,et al. Revaluación del método estándar (criterios de Light) para identificar exudados pleurales , 2006 .
[35] J. M. Porcel,et al. Tuberculous Pleural Effusion , 2009, Lung.
[36] J. Jónasson,et al. The cell block for body cavity fluids: do the results justify the cost? , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[37] R. Light,et al. Clinical practice. Pleural effusion. , 2002, The New England journal of medicine.
[38] R. Light,et al. Update on tuberculous pleural effusion , 2010, Respirology.
[39] J. Arenas,et al. Amylase levels in pleural effusions: a consecutive unselected series of 841 patients. , 2002, Chest.
[40] R. Morice,et al. Medical thoracoscopy , 2009, Current opinion in pulmonary medicine.
[41] F. Galateau-Sallé,et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma , 2009, European Respiratory Journal.
[42] M. Murphy,et al. Biochemical analysis of pleural and ascitic fluid: effect of sample timing on interpretation of results , 2007, Annals of clinical biochemistry.
[43] S. Martínez-Somolinos,et al. Importancia de la determinación de la amilasa pleural en los pacientes con derrame neoplásico , 2007 .
[44] F. Maldonado,et al. Pleural fluid characteristics of chylothorax. , 2008, Mayo Clinic proceedings.
[45] T. Morgenthaler,et al. Low yield of microbiologic studies on pleural fluid specimens. , 2005, Chest.
[46] M. Pratter,et al. A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion. , 2008, Chest.
[47] S. Bielsa,et al. Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. , 2009, American journal of respiratory and critical care medicine.
[48] J. M. Porcel,et al. [Parapneumonic pleural effusions and empyema in adults:current practice]. , 2009, Revista clinica espanola.
[49] N. Langeland,et al. Adenosine Deaminase Activity Is a Sensitive Marker for the Diagnosis of Tuberculous Pleuritis in Patients with Very Low CD4 Counts , 2008, PloS one.
[50] M. Odida,et al. Evaluation of suspected tuberculous pleurisy: clinical and diagnostic findings in HIV-1-positive and HIV-negative adults in Uganda. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[51] R. Light,et al. Analysis of pleural effusions in acute pulmonary embolism: Radiological and pleural fluid data from 230 patients , 2007, Respirology.
[52] Sharangouda J. Patil,et al. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma , 2010, Diagnostic cytopathology.
[53] N. Kurata. [Adenosine deaminase]. , 2020, Nihon rinsho. Japanese journal of clinical medicine.
[54] T. Chandler,et al. Comparison of the use and accuracy of methods for determining pleural fluid pH. , 1999, Southern medical journal.